James Gatewood
Hematology & Oncology · New Orleans, LANPI 1417153263
Payments from drug & device makers
Across 145 payments — averaging $18.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$482
- E.r. Squibb & Sons, L.L.C.$265
- Amgen$216
- Novartis$202
- Genentech USA, Inc.$200
- Exelixis Inc.$155
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,692100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 18 | $482 |
| E.r. Squibb & Sons, L.L.C. | 17 | $265 |
| Amgen | 11 | $216 |
| Novartis | 11 | $202 |
| Genentech USA, Inc. | 17 | $200 |
| Exelixis Inc. | 4 | $155 |
| Johnson & Johnson | 4 | $142 |
| AstraZeneca(2 entities) | 7 | $113 |
| Bayer | 5 | $73 |
| Bristol Myers Squibb | 4 | $73 |
| Lilly USA, LLC | 5 | $68 |
| Sanofi | 3 | $52 |
| Puma Biotechnology, Inc. | 3 | $48 |
| Incyte Corporation | 3 | $47 |
| Tesaro, Inc. | 2 | $45 |
| Pfizer | 3 | $41 |
| Taiho Oncology, Inc. | 2 | $41 |
| Gilead | 3 | $37 |
| EMD Serono, Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| AbbVie | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Astellas Pharma US Inc | 1 | $24 |
| EUSA Pharma (US) LLC | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Foundation Medicine, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Biocompatibles, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Verastem, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Dova Pharmaceuticals | 1 | $17 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,692 in reported general payments places this provider in the 25th percentile of 183 hematology & oncology providers in Louisiana.
Other hematology & oncology in New Orleans
- Marc MatranaNew Orleans$4.6M
- Pedro BarataNew Orleans$4.2M
- Carter DavisNew Orleans$1.6M
- Maissaa JanbainNew Orleans$1.5M
- Lingling duNew Orleans$1.2M
- John ColeNew Orleans$896K
- Cindy LeissingerNew Orleans$432K
- Furhan YunusNew Orleans$422K
- David MorrisonNew Orleans$313K
- Stefan GrantNew Orleans$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.